Breaking News
Get 40% Off 0
Is NVDA a 🟢 buy or 🔴 sell? Unlock Now
Close

Roche Holding AG Participation (RHHVF)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
264.18 +5.59    +2.16%
23/02 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 1,833
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 258.50 - 267.20
Roche Holding Participation 264.18 +5.59 +2.16%

RHHVF Balance Sheet

 
Featured here, the Balance Sheet for Roche Holding AG Participation, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 33446 33446 30976 30976
Cash and Short Term Investments 10511 10511 7509 7509
Cash - - - -
Cash & Equivalents 5376 5376 3720 3720
Short Term Investments 5133 5133 3789 3789
Total Receivables, Net 12919 12919 11359 11359
Accounts Receivables - Trade, Net 11548 11548 11089 11089
Total Inventory 7749 7749 8496 8496
Prepaid Expenses 1144 1144 - -
Other Current Assets, Total 1123 1123 3612 3612
Total Assets 90468 90468 84370 84370
Property/Plant/Equipment, Total - Net 22939 22939 23895 23895
Property/Plant/Equipment, Total - Gross 46198 46198 - -
Accumulated Depreciation, Total -23259 -23259 - -
Goodwill, Net 9390 9390 10564 10564
Intangibles, Net 14828 14828 9129 9129
Long Term Investments 789 789 - -
Note Receivable - Long Term 1316 1316 270 270
Other Long Term Assets, Total 2168 2168 3139 3139
Other Assets, Total 8051 8051 11205 11205
Total Current Liabilities 24824 24824 26208 26208
Accounts Payable 3784 3784 4055 4055
Payable/Accrued - - - -
Accrued Expenses 11430 11430 - -
Notes Payable/Short Term Debt 848 848 1669 1669
Current Port. of LT Debt/Capital Leases 3911 3911 3372 3372
Other Current liabilities, Total 4851 4851 17112 17112
Total Liabilities 57205 57205 54026 54026
Total Long Term Debt 26091 26091 21503 21503
Long Term Debt 24809 24809 20345 20345
Capital Lease Obligations 1282 1282 1158 1158
Deferred Income Tax 593 593 671 671
Minority Interest 3948 3948 3829 3829
Other Liabilities, Total 354 901 -245 146
Total Equity 33263 33263 30344 30344
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 107 107 107 107
Additional Paid-In Capital - - - -
Retained Earnings (Accumulated Deficit) 42347 42347 38333 38333
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -9191 -9191 -8096 -8096
Total Liabilities & Shareholders' Equity 90468 90468 84370 84370
Total Common Shares Outstanding 106.69 106.69 106.69 106.69
Total Preferred Shares Outstanding - - - -
* In Millions of CHF (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ROG Comments

Write your thoughts about Roche Holding AG Participation
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mikel ibanez
Mikel ibanez Dec 04, 2023 6:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
18 per and 4% dividend starts looking good. Long hold and nice life investment in one of Europe best companies in a non hype sector
BOXING HUANG
BOXING HUANG Oct 19, 2023 6:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What happened today?
Giancarlo Velotti
Giancarlo Velotti Jul 13, 2023 3:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It is a buy at 266
taja maja
taja maja Jan 26, 2023 2:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
When ist best time to buy?
Scott Goldie
Scott Goldie Jan 17, 2023 5:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
SP suffering since May 2022 due to decline in COVID vaccines.
Jonah Garber
Jonah Garber Jul 24, 2022 12:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
macd indicators showing a nice jump coming, keeping my fingers crossed during these dark times
BOXING HUANG
BOXING HUANG May 11, 2022 4:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What happened today?
Tvynis Jutvynis
Tvynis Jutvynis May 11, 2022 4:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The SKYSCRAPER-01 study evaluating tiragolumab plus Tecentriq did not meet its co-primary endpoint of progression-free survival
Tvynis Jutvynis
Tvynis Jutvynis May 11, 2022 4:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Today only this info about Roche
Sherlyn Jones
Sherlyn Jones Apr 22, 2021 6:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
A large pharmaceutical company, by the name of R. , is pushing down the value of the Spanish company's Pharmamar share price through the funds Consonance Capital and Great Point Partners, so that the biotech company accepts its offer of more than 4500 million dollars.According to this pharma, Pharmamar's products have a great future in oncology and virology, and would be fully engaged in its search for new drugs.
Financial Advisors
Financial Advisors Apr 22, 2021 6:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hello to Marinopoulos Pharma company .!
José Spescha
José Spescha Mar 18, 2021 4:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Trades ex dividend!!
Victor Garcia
Victor Garcia Feb 01, 2021 2:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Currently near to Fibo 61.8 levels, a great company to buy IMO.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email